Author
Listed:
- Mark B. Pepys
(Royal Free and University College Medical School, University College London)
- Gideon M. Hirschfield
(Royal Free and University College Medical School, University College London
Addenbrookes Hospital)
- Glenys A. Tennent
(Royal Free and University College Medical School, University College London)
- J. Ruth Gallimore
(Royal Free and University College Medical School, University College London)
- Melvyn C. Kahan
(Royal Free and University College Medical School, University College London)
- Vittorio Bellotti
(Royal Free and University College Medical School, University College London
Universitá di Pavia)
- Philip N. Hawkins
(Royal Free and University College Medical School, University College London)
- Rebecca M. Myers
(University of Cambridge)
- Martin D. Smith
(University of Cambridge)
- Alessandra Polara
(University of Cambridge)
- Alexander J. A. Cobb
(Royal Free and University College Medical School, University College London
University of Reading)
- Steven V. Ley
(University of Cambridge)
- J. Andrew Aquilina
(University of Cambridge
University of Wollongong)
- Carol V. Robinson
(University of Cambridge)
- Isam Sharif
(University of Edinburgh)
- Gillian A. Gray
(University of Edinburgh)
- Caroline A. Sabin
(Royal Free and University College Medical School, University College London)
- Michelle C. Jenvey
(University of Southampton)
- Simon E. Kolstoe
(University of Southampton)
- Darren Thompson
(University of Southampton
University of Sussex)
- Stephen P. Wood
(University of Southampton)
Abstract
Aiming for the heart C-reactive protein (CRP) is a clinical marker for inflammatory disease and infection, but it also binds to damaged cells and activates complement, a host defence and pro-inflammatory system of serum proteins. Complement-mediated inflammation exacerbates tissue injury in heart attacks, and human CRP increases damage in a rat model of acute myocardial infarction via a complement-dependent mechanism. These observations point to CRP as a possible target for drugs intended to protect the heart. Pepys et al. therefore designed a specific small-molecule CRP inhibitor. Five molecules of this palindromic compound are bound by two pentameric CRP molecules arranged face-to-face, as in the X-ray crystal structure of the complex on the cover. The inhibitor blocks the adverse effects of human CRP in rats with acute myocardial infarction, suggesting that early therapeutic inhibition of CRP might be beneficial for heart attack patients.
Suggested Citation
Mark B. Pepys & Gideon M. Hirschfield & Glenys A. Tennent & J. Ruth Gallimore & Melvyn C. Kahan & Vittorio Bellotti & Philip N. Hawkins & Rebecca M. Myers & Martin D. Smith & Alessandra Polara & Alexa, 2006.
"Targeting C-reactive protein for the treatment of cardiovascular disease,"
Nature, Nature, vol. 440(7088), pages 1217-1221, April.
Handle:
RePEc:nat:nature:v:440:y:2006:i:7088:d:10.1038_nature04672
DOI: 10.1038/nature04672
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Debbie A Lawlor & Roger M Harbord & Nic J Timpson & Gordon D O Lowe & Ann Rumley & Tom R Gaunt & Ian Baker & John W G Yarnell & Mika Kivimäki & Meena Kumari & Paul E Norman & Konrad Jamrozik & Graeme , 2008.
"The Association of C-Reactive Protein and CRP Genotype with Coronary Heart Disease: Findings from Five Studies with 4,610 Cases amongst 18,637 Participants,"
PLOS ONE, Public Library of Science, vol. 3(8), pages 1-14, August.
- Carlos A Labarrere & John R Woods & James W Hardin & Beate R Jaeger & Marian Zembala & Mario C Deng & Ghassan S Kassab, 2014.
"Early Inflammatory Markers Are Independent Predictors of Cardiac Allograft Vasculopathy in Heart-Transplant Recipients,"
PLOS ONE, Public Library of Science, vol. 9(12), pages 1-18, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:440:y:2006:i:7088:d:10.1038_nature04672. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.